Cajolo, Ritchel B.

HRN: 27-34-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
MUPIROCIN 2%, 15G (TUBE)
07/09/2025
07/15/2025
TOPICAL
Apply Liberally
OD
S/P USO
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: